Traditional Chinese medicine for treating qi-blood deficiency urticaria

A technology for qi and blood deficiency and urticaria, which is applied in the directions of arthropod medical raw materials, drug combinations, pharmaceutical formulations, etc., can solve problems such as drug dependence, aggravation of primary lesions at the drug site, and achieve quick and reliable curative effects. Effect

Inactive Publication Date: 2016-06-01
黄庆辉
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long-term or high-dose external use of corticosteroids will lead to addiction and drug dependence. Once the drug is stopped, the primary lesion at the drug site will aggravate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039]A traditional Chinese medicine for treating urticaria of both qi and blood deficiency type, which is composed of the following raw materials in the weight ratio: 20 parts of Astragalus, 15 parts of Fangfeng, 15 parts of Atractylodes Rhizoma Atractylodes Rhizome, 12 parts of Schizonepeta, 12 parts of Angelica sinensis, and 12 parts of Rehmannia glutinosa 15 parts of Radix Paeoniae Alba, 9 parts of Chuanxiong, 15 parts of Codonopsis Codonopsis, 15 parts of Poria cocos, 8 parts of cicada slough, 8 parts of Tribulus terrestris, 6 parts of licorice.

Embodiment 2

[0041] A traditional Chinese medicine for treating urticaria of both qi and blood deficiency, which is composed of the following raw materials in the weight ratio: 15 parts of astragalus, 15 parts of Fangfeng, 12 parts of Atractylodes macrocephala, 10 parts of Schizonepeta, 10 parts of angelica, and 10 parts of rehmannia glutinosa 15 parts of Radix Paeoniae Alba, 8 parts of Rhizoma Chuanxiong, 10 parts of Codonopsis Codonopsis, 12 parts of Poria cocos, 6 parts of cicada slough, 8 parts of Tribulus terrestris, 5 parts of licorice.

Embodiment 3

[0043] A traditional Chinese medicine for treating urticaria of both qi and blood deficiency type, which is composed of the following raw materials in the weight ratio: 25 parts of Astragalus, 20 parts of Fangfeng, 15 parts of Atractylodes Rhizoma Atractylodes Rhizome, 15 parts of Schizonepeta, 15 parts of Angelica sinensis, and 15 parts of Rehmannia glutinosa 25 parts of Radix Paeoniae Alba, 15 parts of Rhizoma Chuanxiong, 15 parts of Codonopsis Codonopsis, 18 parts of Poria cocos, 10 parts of cicada slough, 12 parts of Tribulus terrestris, 9 parts of licorice.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a traditional Chinese medicine for treating qi-blood deficiency urticaria, which is prepared from the following raw medicines in parts by weight: 15-25 parts of astragalus root, 15-20 parts of radix sileris, 12-15 parts of white atractylodes rhizome, 10-15 parts of herba schizonepetae, 10-15 parts of angelica, 10-15 parts of prepared rehmannia root, 15-25 parts of white peony root, 8-15 parts of chuanxiong rhizome, 10-15 parts of dangshen, 12-18 parts of tuckahoe, 6-10 parts of cicada slough, 8-12 parts of tribulus terrestris and 5-9 parts of licorice. The traditional Chinese medicine has the effects on invigorating qi and tonifying the blood, nourishing the blood to expel wind as well as consolidating superficial resistance and promoting eruption, and has the characteristics of reliable curative effect, high effect taking speed, no side effect and the like when used for treating qi-blood deficiency urticaria.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating urticaria of deficiency of both qi and blood. Background technique [0002] Urticaria, commonly known as wheal, is a common skin disease. Various factors lead to temporary inflammatory congestion and a large amount of fluid exudation in the blood vessels of the skin and mucous membranes. Cause local edematous damage. It occurs rapidly and subsides, with severe itching. May have fever, abdominal pain, diarrhea or other systemic symptoms. [0003] Clinical manifestations: The basic damage is the appearance of wheals on the skin. Often have skin pruritus first, then wheal occurs, and is bright red or pale, skin color, and a few patients have edematous erythema. The size and shape of the wheal vary, and the outbreak time is indefinite. The wheal gradually spread and merged into sheets. Due to dermal papillary edema, it can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/804A61P17/00A61K35/64
CPCA61K36/481A61K35/63A61K36/076A61K36/185A61K36/232A61K36/236A61K36/238A61K36/284A61K36/344A61K36/484A61K36/538A61K36/65A61K36/71A61K36/804A61K2300/00
Inventor 李土才
Owner 黄庆辉
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap